Skip to main content
Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery 2/2020

05.09.2019 | Original Article

Optimal timing of renal replacement therapy for favourable outcome in patients of acute renal failure following cardiac surgery

verfasst von: Shanshank Tripathi, Shantanu Pande, Pulkit Malhotra, Supaksh Mahindru, Ankit Thukral, Ankush Singh Kotwal, Gauranga Majumdar, Surendra Kumar Agarwal, Amit Gupta

Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Acute renal failure is a serious complication following cardiac surgery. This may lead to fatal outcome if not treated timely. Continuous renal replacement therapy (RRT) has shown improvement in outcome. There is no clear consensus on the timing of the initiation of RRT in these patients. This study evaluates the factors predicting favourable outcome in this group of patients.

Methods

Patients undergoing cardiac surgery between January 2015 and December 2018 are included in this retrospective study. RRT is required in 24 patients out of 2254 operated during this period. Patients are divided into groups, survivors (group 1, n = 8) and dead (group 2, n = 16). The preoperative information is accessed from the hospital information system and intensive care unit data. Multivariate analysis of pre continuous renal replacement therapy (CRRT) bicarbonate level, pH, potassium, time of initiating CRRT and central venous pressure is performed.

Results

The incidence of acute renal failure requiring RRT is 1.06%. Patients in two groups were similar in demographics and presence of risk factors. There was difference in the pre RRT bicarbonate level (p = 0.007). On multivariate analysis, pre RRT bicarbonate levels predict survival (p = 0.003). ROC curve for pre RRT bicarbonate predicts survival for value above 16.83 mg/dl with 80% sensitivity and 78.6% specificity.

Conclusion

Bicarbonate level in blood predicts the best evidence for initiating the renal replacement therapy in of acute renal failure following cardiac surgery. When urine output drops to < 0.5 ml/kg and not responding to infusion of furosemide, RRT must be initiated at sodium bicarbonate in blood above 16.9 mg%.
Literatur
1.
Zurück zum Zitat Norman JC, Mcdonald HP, Sloan H. The early and aggressive treatment of acute renal failure following cardiopulmonary bypass with continuous peritoneal dialysis. Surgery. 1964;56:240–8. Norman JC, Mcdonald HP, Sloan H. The early and aggressive treatment of acute renal failure following cardiopulmonary bypass with continuous peritoneal dialysis. Surgery. 1964;56:240–8.
2.
Zurück zum Zitat Abel RM, Buckley MJ, Austen WG, Barnett GO, Beck CH Jr, Fischer JE. Etiology, incidence, and prognosis of renal failure following cardiac operations. Results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg. 1976;71:323–33.CrossRef Abel RM, Buckley MJ, Austen WG, Barnett GO, Beck CH Jr, Fischer JE. Etiology, incidence, and prognosis of renal failure following cardiac operations. Results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg. 1976;71:323–33.CrossRef
3.
Zurück zum Zitat Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107:1489–95. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107:1489–95.
4.
Zurück zum Zitat Gailiunas P Jr, Chawla R, Lazarus JM, Cohn L, Sanders J, Merrill JP. Acute renal failure following cardiac operations. J Thorac Cardiovasc Surg. 1980;79:241–3.CrossRef Gailiunas P Jr, Chawla R, Lazarus JM, Cohn L, Sanders J, Merrill JP. Acute renal failure following cardiac operations. J Thorac Cardiovasc Surg. 1980;79:241–3.CrossRef
5.
Zurück zum Zitat Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–8. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–8.
6.
Zurück zum Zitat Belley-Côté EP, Parikh CR, Shortt CR, et al. Association of cardiac biomarkers with acute kidney injury after cardiac surgery: a multicenter cohort study. J Thorac Cardiovasc Surg. 2016;152:245–51.CrossRef Belley-Côté EP, Parikh CR, Shortt CR, et al. Association of cardiac biomarkers with acute kidney injury after cardiac surgery: a multicenter cohort study. J Thorac Cardiovasc Surg. 2016;152:245–51.CrossRef
7.
Zurück zum Zitat Sato Y, Kato TS, Oishi A, et al. Preoperative factors associated with postoperative requirements of renal replacement therapy following cardiac surgery. Am J Cardiol. 2015;116:294–300.CrossRef Sato Y, Kato TS, Oishi A, et al. Preoperative factors associated with postoperative requirements of renal replacement therapy following cardiac surgery. Am J Cardiol. 2015;116:294–300.CrossRef
8.
Zurück zum Zitat Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–8.CrossRef Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–8.CrossRef
9.
Zurück zum Zitat Molnar AO, Parikh CR, Coca SG, et al. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg. 2014;97:2081–7.CrossRef Molnar AO, Parikh CR, Coca SG, et al. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg. 2014;97:2081–7.CrossRef
10.
Zurück zum Zitat Cogliati AA, Vellutini R, Nardini A, et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth. 2007;21:847–50.CrossRef Cogliati AA, Vellutini R, Nardini A, et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth. 2007;21:847–50.CrossRef
11.
Zurück zum Zitat Billings FT 4th, Hendricks PA, Schildcrout JS, et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877–88.CrossRef Billings FT 4th, Hendricks PA, Schildcrout JS, et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877–88.CrossRef
12.
Zurück zum Zitat Engoren M, Habib RH, Arslanian-Engoren C, Kheterpal S, Schwann TA. The effect of acute kidney injury and discharge creatinine level on mortality following cardiac surgery. Crit Care Med. 2014;42:2069–74.CrossRef Engoren M, Habib RH, Arslanian-Engoren C, Kheterpal S, Schwann TA. The effect of acute kidney injury and discharge creatinine level on mortality following cardiac surgery. Crit Care Med. 2014;42:2069–74.CrossRef
13.
Zurück zum Zitat Demirkiliç U, Kuralay E, Yenicesu M, et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg. 2004;19:17–20.CrossRef Demirkiliç U, Kuralay E, Yenicesu M, et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg. 2004;19:17–20.CrossRef
14.
Zurück zum Zitat Kunt AT, Akgün S, Atalan N, Bitir N, Arsan S. Furosemide infusion prevents the requirement of renal replacement therapy after cardiac surgery. Anadolu Kardiyol Derg. 2009;9:499–504. Kunt AT, Akgün S, Atalan N, Bitir N, Arsan S. Furosemide infusion prevents the requirement of renal replacement therapy after cardiac surgery. Anadolu Kardiyol Derg. 2009;9:499–504.
15.
Zurück zum Zitat Gandhi A, Husain M, Salhiyyah K, Raja SG. Does perioperative furosemide usage reduce the need for renal replacement therapy in cardiac surgery patients? Interact Cardiovasc Thorac Surg. 2012;15:750–5.CrossRef Gandhi A, Husain M, Salhiyyah K, Raja SG. Does perioperative furosemide usage reduce the need for renal replacement therapy in cardiac surgery patients? Interact Cardiovasc Thorac Surg. 2012;15:750–5.CrossRef
16.
Zurück zum Zitat Stallwood MI, Grayson AD, Mills K, Scawn ND. Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. Ann Thorac Surg. 2004;77:968–72.CrossRef Stallwood MI, Grayson AD, Mills K, Scawn ND. Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. Ann Thorac Surg. 2004;77:968–72.CrossRef
17.
Zurück zum Zitat Ranucci M, Aloisio T, Cazzaniga A, Di Dedda U, Gallazzi C, Pistuddi V. Validation of renal-risk models for the prediction of non-renal replacement therapy cardiac surgery-associated acute kidney injury. Int J Cardiol. 2018;272:49–53.CrossRef Ranucci M, Aloisio T, Cazzaniga A, Di Dedda U, Gallazzi C, Pistuddi V. Validation of renal-risk models for the prediction of non-renal replacement therapy cardiac surgery-associated acute kidney injury. Int J Cardiol. 2018;272:49–53.CrossRef
18.
Zurück zum Zitat Sun S, Ma F, Li Q, et al. Risk model for deaths and renal replacement therapy dependence in patients with acute kidney injury after cardiac surgery. Interact Cardiovasc Thorac Surg. 2017;25:548–54.CrossRef Sun S, Ma F, Li Q, et al. Risk model for deaths and renal replacement therapy dependence in patients with acute kidney injury after cardiac surgery. Interact Cardiovasc Thorac Surg. 2017;25:548–54.CrossRef
19.
Zurück zum Zitat Pistolesi V, Di Napoli A, Fiaccadori E, et al. Severe acute kidney injury following cardiac surgery: short-term outcomes in patients undergoing continuous renal replacement therapy (CRRT). J Nephrol. 2016;29:229–39.CrossRef Pistolesi V, Di Napoli A, Fiaccadori E, et al. Severe acute kidney injury following cardiac surgery: short-term outcomes in patients undergoing continuous renal replacement therapy (CRRT). J Nephrol. 2016;29:229–39.CrossRef
20.
Zurück zum Zitat Branch-Elliman W, Ripollone JE, O'Brien WJ, et al. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study. PLoS Med. 2017;14:e1002340.CrossRef Branch-Elliman W, Ripollone JE, O'Brien WJ, et al. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study. PLoS Med. 2017;14:e1002340.CrossRef
21.
Zurück zum Zitat Mcllroy DR, Argenziano M, Farkas D, Umann T, Sladen RN. Incorporating oliguria into the diagnostic criteria for acute kidney injury after on-pump cardiac surgery: impact on incidence and outcomes. J Cardiothorac Vasc Anesth. 2013;27:1145–52. Mcllroy DR, Argenziano M, Farkas D, Umann T, Sladen RN. Incorporating oliguria into the diagnostic criteria for acute kidney injury after on-pump cardiac surgery: impact on incidence and outcomes. J Cardiothorac Vasc Anesth. 2013;27:1145–52.
22.
Zurück zum Zitat Ji Q, Mei Y, Wang X, et al. Risk factors for failure of continuous veno-venous hemodialysis in the treatment of acute renal failure following cardiac surgery. Perfusion. 2010;25:337-42.CrossRef Ji Q, Mei Y, Wang X, et al. Risk factors for failure of continuous veno-venous hemodialysis in the treatment of acute renal failure following cardiac surgery. Perfusion. 2010;25:337-42.CrossRef
23.
Zurück zum Zitat Ji Q, Mei Y, Wang X, et al. Timing of continuous veno-venous hemodialysis in the treatment of acute renal failure following cardiac surgery. Heart Vessels. 2011;26:183-9.CrossRef Ji Q, Mei Y, Wang X, et al. Timing of continuous veno-venous hemodialysis in the treatment of acute renal failure following cardiac surgery. Heart Vessels. 2011;26:183-9.CrossRef
24.
Zurück zum Zitat Cóndor JM, Rodrigues CE, Sousa Moreira Rd, et al. Treatment with human wharton's jelly-derived mesenchymal stem cells attenuates sepsis-induced kidney injury, liver injury, and endothelial dysfunction. Stem Cells Transl Med. 2016;5:1048-57.CrossRef Cóndor JM, Rodrigues CE, Sousa Moreira Rd, et al. Treatment with human wharton's jelly-derived mesenchymal stem cells attenuates sepsis-induced kidney injury, liver injury, and endothelial dysfunction. Stem Cells Transl Med. 2016;5:1048-57.CrossRef
25.
Zurück zum Zitat Torino C, Mattace-Raso F, van Saase JL, et al. Oxidative stress as estimated by gamma-glutamyl transferase levels amplifies the alkaline phosphatase-dependent risk for mortality in ESKD patients on dialysis. Oxid Med Cell Longev. 2016;2016:8490643. https://doi.org/10.1155/2016/8490643.CrossRef Torino C, Mattace-Raso F, van Saase JL, et al. Oxidative stress as estimated by gamma-glutamyl transferase levels amplifies the alkaline phosphatase-dependent risk for mortality in ESKD patients on dialysis. Oxid Med Cell Longev. 2016;2016:8490643. https://​doi.​org/​10.​1155/​2016/​8490643.CrossRef
28.
Zurück zum Zitat Wu SC, Fu CY, Lin HH, et al. Late initiation of continuous veno-venous hemofiltration therapy is associated with a lower survival rate in surgical critically ill patients with postoperative acute kidney injury. Am Surg. 2012;78:235–42. Wu SC, Fu CY, Lin HH, et al. Late initiation of continuous veno-venous hemofiltration therapy is associated with a lower survival rate in surgical critically ill patients with postoperative acute kidney injury. Am Surg. 2012;78:235–42.
29.
Zurück zum Zitat Wei SS, Lee GS, Woo KT, Lim CH. Acute renal failure prognostic indices in hospital inpatients referred for haemodialysis. Ann Acad Med Singap. 1991;20:331–4. Wei SS, Lee GS, Woo KT, Lim CH. Acute renal failure prognostic indices in hospital inpatients referred for haemodialysis. Ann Acad Med Singap. 1991;20:331–4.
30.
32.
Zurück zum Zitat Vaughan-Jones RD, Spitzer KW. Role of bicarbonate in the regulation of intracellular pH in the mammalian ventricular myocyte. Biochem Cell Biol. 2002;80:579–96.CrossRef Vaughan-Jones RD, Spitzer KW. Role of bicarbonate in the regulation of intracellular pH in the mammalian ventricular myocyte. Biochem Cell Biol. 2002;80:579–96.CrossRef
33.
Zurück zum Zitat Casey JR. Why bicarbonate? Biochem Cell Biol. 2006;84:930–9. Casey JR. Why bicarbonate? Biochem Cell Biol. 2006;84:930–9.
34.
Zurück zum Zitat Steinthorsdottir KJ, Kandler K, AgerlinWindeløv N, Steinbrüchel DA. Renal replacement therapy after cardiac surgery; renal function recovers. Scand Cardiovasc J. 2013;47:303–6.CrossRef Steinthorsdottir KJ, Kandler K, AgerlinWindeløv N, Steinbrüchel DA. Renal replacement therapy after cardiac surgery; renal function recovers. Scand Cardiovasc J. 2013;47:303–6.CrossRef
35.
Zurück zum Zitat Srivastava V, D'Silva C, Tang A, Sogliani F, Ngaage DL. The impact of major perioperative renal insult on long-term renal function and survival after cardiac surgery. Interact Cardiovasc Thorac Surg. 2012;15:14–7.CrossRef Srivastava V, D'Silva C, Tang A, Sogliani F, Ngaage DL. The impact of major perioperative renal insult on long-term renal function and survival after cardiac surgery. Interact Cardiovasc Thorac Surg. 2012;15:14–7.CrossRef
Metadaten
Titel
Optimal timing of renal replacement therapy for favourable outcome in patients of acute renal failure following cardiac surgery
verfasst von
Shanshank Tripathi
Shantanu Pande
Pulkit Malhotra
Supaksh Mahindru
Ankit Thukral
Ankush Singh Kotwal
Gauranga Majumdar
Surendra Kumar Agarwal
Amit Gupta
Publikationsdatum
05.09.2019
Verlag
Springer Singapore
Erschienen in
Indian Journal of Thoracic and Cardiovascular Surgery / Ausgabe 2/2020
Print ISSN: 0970-9134
Elektronische ISSN: 0973-7723
DOI
https://doi.org/10.1007/s12055-019-00856-5

Weitere Artikel der Ausgabe 2/2020

Indian Journal of Thoracic and Cardiovascular Surgery 2/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.